This review not only extends the body of knowledge regarding the role that DUBs play in regulating host innate immune signaling pathways in viral infections, but also describes how targeting DUBs could be utilized to develop DUB inhibitors that could be applied to yield therapies for clinically relevant viral infections. Here, ZUP1 is linked to viral infectious disease.